PAUL WALKER is listed as a director on 3 SEC Form D filings by 2 issuers between May 2017 and Apr 2018: Allakos Inc. (San Carlos, CA — biotechnology — 2017; $100.1M reported sold to 40 investors) and Tracon Pharmaceuticals, Inc. (San Diego, CA — biotechnology — 2017–2018; $38.7M reported sold to 15 investors).
What this means 2 separate companies raised money with this person listed as director. Across those companies the filings report $138.8M sold in total.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 7 bankruptcy cases matching the name listed in Key records below.
What this means 7 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 3 public filings for PAUL WALKER and found 9 differences: Form D filed 18 days after the first sale; Form D filed 57 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.